Virtual Investor Co.

Sabrina Martucci Johnson, CEO of @Darebioscience, joined a #WhatThisMeans segment to discuss the FDA clearance of the IND for DARE-HPV and the planned Phase 2 clinical study, highlighting what this milestone could mean for women’s health. 🔗: vimeo.com/1172599752/73e… $DARE

⏰ Starting Soon! $ERNA is going live in the #VirtualInvestor Closing Bell event. Tune in for the latest updates and submit your questions during the live Q&A. Join here 👇 bit.ly/3ZS84Ht #CancerResearch #DeliveringHope @ernexatx

🔔 Tune In Today at 4 PM ET! Catch @ernexatx live in their #VirtualInvestor Closing Bell segment for the latest corporate updates, key progress highlights, and a look at upcoming initiatives. Watch live here: bit.ly/3ZS84Ht $ERNA #CancerResearch #DeliveringHope

⏰ Happening Tomorrow at 4 PM ET Catch CEO Sanjeev Luther live as he shares $ERNA’s latest insights during a #VirtualInvestor Closing Bell session. Don’t miss this opportunity! Register here: bit.ly/3ZS84Ht #CancerResearch #DeliveringHope @ernexatx

📅 Mark Your Calendars! $ERNA will participate in a #VirtualInvestor Closing Bell segment on February 25 at 4 PM ET. Hear the latest corporate updates directly from CEO Sanjeev Luther. Sign up here: bit.ly/3ZS84Ht #CancerResearch #DeliveringHope @ernexatx

Starting Now! @AimImmuno is LIVE in the #VirtualInvestor Closing Bell segment! Tune in to hear CEO Thomas Equals discuss their clinical and regulatory strategy for its lead drug Ampligen. 👉 Access the event here: bit.ly/4tNCecQ $AIM #Oncology #PancreaticCancer #PanCan

🔔 LIVE Today! @AimImmuno will be on the air at 4 PM ET for a #VirtualInvestor Closing Bell segment with CEO Thomas Equels. Get the latest updates and insights here: bit.ly/4tNCecQ $AIM #CancerResearch #Oncology #PancreaticCancer #PanCan

#GetReady! Tomorrow at 4 PM ET, don't miss @AimImmuno in the #VirtualInvestor Closing Bell Series. Tune in to hear directly from CEO Thomas Equels and get your questions answered live! Register here: bit.ly/4tNCecQ $AIM #CancerResearch #Oncology #PancCancer #PanCan

Marc Hertz, CEO of $GRI, joined a #WhatThisMeans segment to discuss the new positive Phase 2a data, including biomarker results showing improvements in key drivers of fibrosis and lung repair. Access the segment here: vimeo.com/1164822001/132… @gri_bio

$AKTX CEO, Abizer Gaslightwala joined #WhatThisMeans to discuss their expanding ADC pipeline, including AKTX-102, their patent strategy and how the PH1-powered platform supports multiple differentiated therapeutic programs. Watch here: vimeo.com/1163757924/ebc… @Akaritx

$DCOY joined #WhatThisMeans to discuss how their manufacturing approach enables rapid scale up of peptide conjugate therapeutics from lab to production and supports a distributed global manufacturing network to address emerging viral threats. vimeo.com/1161634150/24a… @DecoyTX

Sanjeev Luther, President & CEO of Ernexa, joined a #WhatThisMeans to discuss the Company’s recent successful Pre-IND meeting with the U.S. Food and Drug Administration and continued progress toward a first-in-human ovarian cancer trial. Watch here: vimeo.com/1161165089/0ac… $ERNA

Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company’s Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation bit.ly/4qk5yoS $SNTI #CellTherapy #Oncology #AML

CEO of $SNTI, Timothy Lu, MD, PhD, highlighted key milestones for Senti Biosciences, including the FDA’s RMAT designation for SENTI-202 and recently presented clinical data from the Company’s ongoing AML trial. Access the CEO Connect segment: vimeo.com/1154109185/abf… @sentibio

CEO of $AMIX, Brad Hauser, highlighted key priorities for Autonomix, including strengthening its platform through IP protection and exploring opportunities beyond pancreatic cancer. Access the CEO Corner segment to learn more: vimeo.com/1148724941/bdc… @autonomixmed

CEO of @akaritx, Abizer Gaslightwala joined a #WhatThisMeans segment to discuss their novel spliceosome-modulating ADC payload, and new preclinical data highlighting AKTX-101’s potential in hard-to-treat KRAS-mutant pancreatic cancer. Watch here: vimeo.com/1147653580/042… $AKTX

Mark Jensen, Executive Chairman of American Resources, joined a #WhatThisMeans with Jacob Clayton, CEO of SAGINT Inc., to discuss their new partnership bringing blockchain-based tokenization to critical mineral traceability and transparency. Watch here: vimeo.com/1143978433/6fe…

🔔 LIVE Today! @AimImmuno will be on the air at 4 PM ET for a #VirtualInvestor Closing Bell segment with CEO Mr. Thomas Equels Get the latest updates and insights here: bit.ly/3K7x7SN $AIM #CancerResearch #PancreaticCancer

🎥 #InCaseYouMissedIt: We hosted a LIVE CEO Connect segment featuring Rob Berman, CEO of @enVVenoMedical, where he shared a corporate overview and key updates on the Company’s mission in venous disease. Catch the replay and get up to speed 🔗bit.ly/43TH391 $NVNO #CVI

#GetReady! Tomorrow at 4 PM ET, don't miss @AimImmuno in the #VirtualInvestor Closing Bell Series. Tune in to hear directly from CEO Mr. Thomas Equels and get your questions answered live! Register here: bit.ly/3K7x7SN $AIM #CancerResearch #PancreaticCancer